David P. Rotella
About
In The Last Decade
David P. Rotella
55 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 112
- Molecular Biology 702
- Organic Chemistry 509
- Pharmacology 183
- Computational Theory and Mathematics 138
- Psychiatry and Mental health 98
Countries citing papers authored by David P. Rotella
This map shows the geographic impact of David P. Rotella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Rotella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Rotella more than expected).
Fields of papers citing papers by David P. Rotella
This network shows the impact of papers produced by David P. Rotella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Rotella. The network helps show where David P. Rotella may publish in the future.
Co-authorship network of co-authors of David P. Rotella
This figure shows the co-authorship network connecting the top 25 collaborators of David P. Rotella. A scholar is included among the top collaborators of David P. Rotella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David P. Rotella. David P. Rotella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 5 | |
| 7 | 7 | |
| 8 | 4 | |
| 9 | 9 | |
| 10 | 9 | |
| 11 | 30 | |
| 12 | Burger's medicinal chemistry, drug discovery, and development | 126 |
| 13 | Cardiovascular, endocrine, and metabolic diseases | 1 |
| 14 | Methods in drug discovery | 3 |
| 15 | COMP-Structure-Based Design and Development of Estrogen Receptor Modulators. 10-14 September 2006, San Francisco, CA, USA | 1 |
| 16 | SB-480848. GlaxoSmithKline. | 8 |
| 17 | 240 | |
| 18 | A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats | 17 |
| 19 | 24 | |
| 20 | The synthon concept in medicinal chemistry : synthesis and applications of cyclohexane diol diamines / | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.